Edges in Network
| Network | GSE5851_top500tf - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | NR3C1 |
| Upstream (Parents) |
|---|
| (<<) VTN → NR3C1 |
| (<<) NR1H4 → NR3C1 |
| (<<) ESR1 → NR3C1 |
| (<<) HHEX → NR3C1 |
| Downstream (Children) |
|---|
| NR3C1 → ASCL2 (>>) |
| NR3C1 → HOXB13 (>>) |
| NR3C1 → TRIM29 (>>) |
| NR3C1 → PITX1 (>>) |
| NR3C1 → ETV4 (>>) |
| NR3C1 → OVOL1 (>>) |
| NR3C1 → HR (>>) |
| NR3C1 → GRHL2 (>>) |
| NR3C1 → NPAS2 (>>) |
| NR3C1 → TSHZ2 (>>) |
| NR3C1 → MAF (>>) |
| NR3C1 → HEY1 (>>) |
| NR3C1 → ZFPM2 (>>) |
| NR3C1 → CEBPD (>>) |
| NR3C1 → TCF21 (>>) |
| NR3C1 → MNX1 (>>) |
| NR3C1 → TCF4 (>>) |
| NR3C1 → ZEB1 (>>) |
| NR3C1 → NR6A1 (>>) |
| NR3C1 → E2F8 (>>) |
| NR3C1 → CBFA2T3 (>>) |
| NR3C1 → BACH2 (>>) |
| NR3C1 → PLAG1 (>>) |
| NR3C1 → NFIC (>>) |
| NR3C1 → RORA (>>) |
| NR3C1 → SNAI2 (>>) |
| NR3C1 → BCL6 (>>) |
| NR3C1 → E2F5 (>>) |
| NR3C1 → TRIM22 (>>) |
| NR3C1 → PEG3 (>>) |
| NR3C1 → NR4A2 (>>) |
| NR3C1 → MYC (>>) |
| NR3C1 → ZNF165 (>>) |
| NR3C1 → FLI1 (>>) |
| NR3C1 → MEIS2 (>>) |
| NR3C1 → GATA1 (>>) |
| NR3C1 → MAFB (>>) |
| NR3C1 → RARB (>>) |
| NR3C1 → ELF3 (>>) |
| NR3C1 → EPAS1 (>>) |
| NR3C1 → ZFHX4 (>>) |
| NR3C1 → PLAGL2 (>>) |
| NR3C1 → SNAPC4 (>>) |
| NR3C1 → ZEB2 (>>) |
| NR3C1 → E2F1 (>>) |
| NR3C1 → GTF2IRD1 (>>) |
| NR3C1 → HEY2 (>>) |
| NR3C1 → MYCL1 (>>) |
| NR3C1 → HCLS1 (>>) |
| NR3C1 → HOXA6 (>>) |
| NR3C1 → ETS2 (>>) |
| NR3C1 → EGR1 (>>) |
| NR3C1 → RAX (>>) |
| NR3C1 → SREBF1 (>>) |
| NR3C1 → NR2F2 (>>) |
| NR3C1 → RBCK1 (>>) |
| NR3C1 → MEIS3P1 (>>) |
| NR3C1 → KLF11 (>>) |
| NR3C1 → SOX17 (>>) |
